Scientist II - Mass Spec Development
KCAS Bio
About this role
A Scientist II at KCAS Bio works in the Mass Spec Bioanalysis Development group, executing studies from setup to data generation, supporting development activities, and utilizing LCMS techniques for drug discovery and clinical studies.
Skills
Qualifications
About KCAS Bio
kcasbio.comKCAS Bio is a bioanalytical contract research organization (CRO) that supports drug development worldwide across complex therapeutic modalities. They provide GLP/GCP‑compliant bioanalytical services—including PK/PD analysis, method development and validation, immunogenicity and biomarker assays, and regulated sample testing—for small molecules, biologics, and advanced therapies. Clients rely on KCAS Bio for experienced scientific teams, robust quality and regulatory systems, and global project management to accelerate programs from discovery through clinical development.
Recent company news
Via TTThe KCAS Bio – Lyon, France Site Renews Its GLP Compliance Statement, Strengthening Its Support for IND-Enabling Studies Through Bioanalysis and Biomarkers
3 days ago
Yahoo FinanceKCAS Bio Strengthens Board of Directors with Appointment of Paul Kirchgraber and Kurt Doyle
Nov 3, 2025
The Business Journals2025 Champions of Business: KCAS Bio
May 30, 2025
Business WireKCAS Expands Its Transatlantic Presence with the Acquisition of France-based Active Biomarkers
Sep 12, 2022
Business WireKCAS Bioanalytical and Biomarker Services Announces Growth to Scientific Leadership Team
Apr 25, 2023
About KCAS Bio
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for KCAS Bio.